SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotime-Nasdaq's best kept secret?
BTIM 0.00010000.0%Nov 3 2:01 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (1334)6/22/1999 10:22:00 AM
From: Jim Roof  Read Replies (1) of 1432
 
Tuck,

Next qtr's sales figures will undoubtedly be entered as exhibit A in the short's case against BTIM. Seeing as how the product will have just hit the street and the pipeline just opened for consumption there is no doubt in my mind that sales will be weak.

Now, let me remind you that I am long and I am not expecting much at all in the quarter in which rollout begins. Who in their right mind would look for 0-300 mph acceleration in .1 seconds? It will take a while for an accurate gauge to develop on Hextend's actual sales but that will not stop the shorts from heralding triumph when the first sales figures are out. At this point in time I think nobody has any real solid idea on the topic.

Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext